Talphera (TLPH) Net Income (2010 - 2025)

Talphera (TLPH) posted quarterly Net Income of $73000.0 for Q1 2025, up 708.33% quarter-over-quarter from -$12000.0 in Q4 2023.

Talphera (TLPH) Net Income (2010 - 2025) Analysis & Trends

Talphera's Net Income history runs 15 years deep, the most recent figure standing at $73000.0 for Q1 2025.

In Q1 2025, Net Income changed N/A year-over-year to $73000.0; the TTM figure through Dec 2025 stood at $73000.0 (changed N/A YoY), while the FY2025 annual figure was $73000.0, changed N/A from the prior year.
Net Income for Q1 2025 stood at $73000.0, up from -$12000.0 in the prior quarter.
The five-year high for Net Income was $8.2 million in Q1 2023, with the low at -$9.9 million in Q2 2021.
The 4-year median for Net Income is -$1.5 million (2022), against an average of -$2.4 million.
The sharpest annual moves came in 2022 and 2023: Net Income tumbled 185.61% in 2022, then surged 302.41% in 2023.
Talphera's Net Income stood at -$542000.0 in 2021, then sank by 185.61% to -$1.5 million in 2022, then soared by 99.22% to -$12000.0 in 2023, then soared by 708.33% to $73000.0 in 2025.
Business Quant data shows TLPH's Net Income at $73000.0 in Q1 2025, -$12000.0 in Q4 2023, and $61000.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-576.00 Mn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	866.00 Mn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-69.36 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	333.00 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-118.80 Mn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	144.40 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	54.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Talphera	90.63 Mn	90.63 Mn	-	-3.75 Mn

Download Data